Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach

Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach

In COVID-19, pulmonary edema has been attributed to “cytokine storm”. However, it is known that SARS-CoV2 promotes angiotensin-converting enzyme 2 deficit, increases angiotensin II, and this triggers volume overload. Our report is based on COVID-19 patients with tomographic evidence of pulmonary ede...

Full description

Bibliographic Details
Main Authors: Jose L. Francisco Santos, Patricio Zanardi, Veronica Alo, Marcelo Rodriguez, Federico Magdaleno, Virginia De Langhe, Vanina Dos Santos, Giuliana Murialdo, Andrea Villoldo, Micaela Coria, Diego Quiros, Claudio Milicchio, Eduardo Garcia Saiz
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
furosemide
edema
volume overload
diuretic
NEGBAL
Online Access:https://www.mdpi.com/2077-0383/10/23/5599

Internet

https://www.mdpi.com/2077-0383/10/23/5599

Similar Items